Galderma Group AG
GALDSwitzerland
1 filed reports · 98 financial concepts · 6 earnings calls · 0 media appearances
Filed reports
1 reports · Dec 2025Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| AnnualSIX-listed company reports | 1 | 100 | Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2025 | annual | Dec 31, 2025 | Dec 31, 2025 | 100 | Open |
Financial data
98 concepts · 100 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
IFRS97 concepts · 99 facts · Dec 2025
- Accrued interest not paid2 · Dec 2025
- Total Lease Liabilities2 · Dec 2025
- Accruals and deferred income1 · Dec 2025
- Alastin Skincare (trademark)1 · Dec 2025
- Amortization of intangible assets1 · Dec 2025
- Cash and bank balances1 · Dec 2025
- Cash flow hedges – reclassified to profit or loss, net of taxes11 · Dec 2025
- Cash Generated from Operations1 · Dec 2025
- Cost of Goods and Services Sold1 · Dec 2025
- Cumulative translation adjustment1 · Dec 2025
- Currency retranslations1 · Dec 2025
- Current income tax liabilities1 · Dec 2025
- Customer relationships – Injectable Aesthetics1 · Dec 2025
- Customer relationships – Therapeutic Dermatology1 · Dec 2025
- Deferred tax assets1 · Dec 2025
- Deferred tax liabilities1 · Dec 2025
- Depreciation of property, plant and equipment1 · Dec 2025
- Distribution1 · Dec 2025
- Dividends Paid1 · Dec 2025
- Employee benefits assets1 · Dec 2025
- EPS (Basic)1 · Dec 2025
- EPS (Diluted)1 · Dec 2025
- Expenditure on intangible assets1 · Dec 2025
- Expenditure on property, plant and equipment1 · Dec 2025
APM1 concepts · 1 facts · Dec 2025
- Leverage Ratio (adjusted Net Debt to Core EBITDA)1 · Dec 2025
Segments
Figures broken down by business line, region, product or another axis the company reports on.
No segment breakdowns.
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
6 calls · Mar 2025 to Jul 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Jul 23, 2026
- FY2025 Q4Mar 5, 2026
- FY2025 Q3Oct 23, 2025
- FY2025 Q2Jul 24, 2025
- FY2025 Q1Apr 24, 2025
- FY2024 Q4Mar 6, 2025
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.